PeptideDB

α-HNJNAc

CAS No.: 1417906-42-3

α-HNJNAc is a potent, competitive hexosaminidases inhibitor that does not interfer with other glycosidases [1].
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description α-HNJNAc is a potent, competitive hexosaminidases inhibitor that does not interfer with other glycosidases [1].
In vitro α-HNJNAc (10, 100μM) has no effect on GM00737 and GM01426 cell lines, but has some effect on GM02931 cell line with a significant 1.8 fold activity increase. a-HNJNAc (100μM; 3 days) has no toxicity on human HL60 cell proliferation [1]. NAGLU is inhibited more efficiently by a-HNJNAc (67 μM) than by the uncorrectly configured b-HNJNAc (374 μM) [1].
molecular weight 234.25
Molecular formula C9H18N2O5
CAS 1417906-42-3
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year